Wells Fargo’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $797K | Sell |
33,844
-9,474
| -22% | -$223K | ﹤0.01% | 3501 |
|
2025
Q1 | $1.04M | Buy |
43,318
+3,742
| +9% | +$89.9K | ﹤0.01% | 3240 |
|
2024
Q4 | $1.67M | Buy |
39,576
+27,573
| +230% | +$1.17M | ﹤0.01% | 2927 |
|
2024
Q3 | $531K | Sell |
12,003
-475
| -4% | -$21K | ﹤0.01% | 3594 |
|
2024
Q2 | $451K | Sell |
12,478
-673
| -5% | -$24.3K | ﹤0.01% | 3637 |
|
2024
Q1 | $567K | Buy |
13,151
+3,519
| +37% | +$152K | ﹤0.01% | 3469 |
|
2023
Q4 | $148K | Sell |
9,632
-22,771
| -70% | -$350K | ﹤0.01% | 4259 |
|
2023
Q3 | $444K | Buy |
32,403
+18,960
| +141% | +$260K | ﹤0.01% | 3585 |
|
2023
Q2 | $216K | Buy |
13,443
+9,236
| +220% | +$148K | ﹤0.01% | 4304 |
|
2023
Q1 | $32.6K | Buy |
+4,207
| New | +$32.6K | ﹤0.01% | 5096 |
|
2022
Q4 | – | Sell |
-231
| Closed | -$5K | – | 7391 |
|
2022
Q3 | $5K | Sell |
231
-112
| -33% | -$2.42K | ﹤0.01% | 5601 |
|
2022
Q2 | $5K | Sell |
343
-2,612
| -88% | -$38.1K | ﹤0.01% | 5734 |
|
2022
Q1 | $69K | Sell |
2,955
-2,742
| -48% | -$64K | ﹤0.01% | 5181 |
|
2021
Q4 | $152K | Buy |
5,697
+5,650
| +12,021% | +$151K | ﹤0.01% | 5040 |
|
2021
Q3 | $1K | Buy |
47
+19
| +68% | +$404 | ﹤0.01% | 6471 |
|
2021
Q2 | $0 | Buy |
+28
| New | – | ﹤0.01% | 7066 |
|